The Journal of Dermatologic Surgery and Oncology · 1992 · 52 citations · 9 references
Deep Venous ThrombosisHormonal ContraceptiveGynecologyFemale Reproductive FunctionMenstrual CycleOrthopaedic SurgeryReproductive EndocrinologyThrombosisProportional LoweringPeripheral Vascular EffectsWomen's PhysiologyAtherosclerosisLower LimbsHealth SciencesVascular BiologyEndocrinologyPharmacologyOvarian HormoneCardiovascular DiseasePhysiologyVenous SystemMedicineWomen's HealthAnesthesiology
Treatments with estrogens and progestogens are suspected of causing vascular complications either directly or by metabolic consequences. Although many studies have demonstrated an increased incidence of arterial and deep venous thrombosis, since 1970 the dose of estrogens and progesterones have been lowered with a proportional lowering of side effects. After classification of estrogens and progestogens, we studied their peripheral vascular effects. In our study, we demonstrated that the effects of estroprogestogen treatment on the superficial venous system depend on the dose of estrogen and progestogen.
9
Menopause and Coronary Heart Disease
Tavia Gordon · Annals of Internal Medicine · 1978 · 889 citations
ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENT
L. E. Böttiger, G Boman, Gustav Eklund et al. · The Lancet · 1980 · 398 citations
Contraceptive Use, Contraception, Hormonal Contraceptive +11
Increased risk of atherosclerosis in women after the menopause.
Jacqueline C.M. Witteman, Diederick E. Grobbee, F.J. Kok et al. · BMJ · 1989 · 276 citations · Full text